Aurinia Pharmaceuticals
AUPH
AUPH
130 hedge funds and large institutions have $953M invested in Aurinia Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 46 increasing their positions, 31 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
6% more funds holding
Funds holding: 123 → 130 (+7)
1.77% less ownership
Funds ownership: 53.87% → 52.1% (-1.8%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
130
Holding in Top 10
4
Calls
$33.8M
Puts
$24.9M
Top Buyers
| 1 | +$21M | |
| 2 | +$14.4M | |
| 3 | +$8.91M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$8.78M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$6.11M |
Top Sellers
| 1 | -$37.2M | |
| 2 | -$32.6M | |
| 3 | -$13.4M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$11.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$5.83M |